The Readout LOUD: FDA Scrutiny on Duchenne Treatments, Biotech Fugitives, and a C-Suite Shakeup.
admin The biotechnology sector is currently navigating a period of intense regulatory scrutiny, executive turnover, and...
Health
Ebola outbreak nears milestone, but vaccine is close
This legal action is not an isolated incident but rather part of a broader regulatory...
FDA Advisory Committee Meeting on Replimune’s RP1 for Melanoma: A Critical Crossroads for Regulatory Policy and Cancer Immunotherapy.
The Food and Drug Administration (FDA) has convened its Cellular, Tissue, and Gene Therapies Advisory...
Latigo Biotherapeutics Challenges Vertex Dominance with Strong Phase 2 Data for Non-Opioid Pain Candidate LTG-001
The landscape of pain management, long dominated by the shadow of the opioid crisis and...
Trump Administration Launches Pilot Program to Bridge the Gap Between Academic Science and Industry Through New Industry-Integrated PhD Model.
The landscape of American scientific research is currently weathering a period of profound structural transformation,...
End of Medicare drug subsidy gives Democrats new attack line on rising out-of-pocket costs
The decision centers on the termination of what policy experts call the "Premium Stabilization Demonstration,"...
A neglected issue in pedestrian, biker deaths
The most visible symbol of this friction remains Dr. Anthony Fauci, the former director of...
FDA Advisory Committee Confronts Dueling Narratives Over Capricor’s Duchenne Muscular Dystrophy Cell Therapy.
The high-stakes regulatory drama surrounding Capricor Therapeutics and its lead candidate, deramiocel, reached a fever...
Bracing for another Fauci hearing
The subpoena comes at a time when the debate over the "lab leak" hypothesis versus...
Internal Revolt Rocks the American Diabetes Association as Over 200 Members Demand Resignation of Top Leadership Following Expulsion of Scientists.
The escalating crisis within the American Diabetes Association (ADA) reached a fever pitch this week...
